The Traderszone Network

What you need to know for today’s trading day.

Acorda Therapeutics says it will buy fellow drug maker Civitas Therapeutics for $525 million in cash, which will give Acorda rights to Civitas’ treatment candidate for episodes of Parkinson’s disease.
read more

It’s a good-news, bad-news scenario, but you can protect yourself, writes Howard Gold.
read more

The negative action in some key sectors indicates that it’s time to be cautious.

Futures pointed to a strong open Wednesday as stocks looked to bounce back from three straight losses. Nasdaq 100 futures jumped 8 points vs. fair value, S&P 500 futures rallied 3 points, and Dow futures climbed 41 points The Nasdaq and S&P 500 are in their longest slumps since the beginning of the month. But both are close to potential support at their 50-day moving averages.

read more

Jabil Circuit, Paychex and Accenture are also stocks to watch Wednesday.
read more

SunGard, a provider of equity market trading technology, announced the launch of its APT Enterprise platform which provides integrated risk management through an interactive risk dashboard for buysiders.